Comparing surgical and conservative treatments for chronic lymphedema after breast cancer
Official title: The LYMPH Trial - Comparing Microsurgical With Conservative Treatment of Chronic Breast Cancer Associated Lymphedema: Study Protocol of a Pragmatic Randomized International Multicentre Superiority Trial
Run by University Hospital, Basel, Switzerland · NCT05890677 · Data updated 2026-11-12
This study is testing whether surgery can help improve the quality of life for people with chronic lymphedema after breast cancer compared to just using physical therapy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 280 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 36 sites (New Haven, Connecticut and 35 other locations) |
| Status | Recruiting |
| Started | July 14, 2023 |
| Main results expected | September 2027 |
| Study ends | June 2036 |
| Registry record updated | October 22, 2026 |
| Trial ID | NCT05890677 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a history of breast cancer and chronic lymphedema persisting for more than three months.
✕Probably not a fit
Patients with primary congenital lymphedema or those who have previously undergone surgical treatment for lymphedema on the affected side may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate whether lymphatic surgery improves quality of life for patients with chronic breast cancer-related lymphedema compared to conservative treatment alone. Participants will be randomly assigned to receive either surgical intervention or conservative complex physical decongestion therapy, which includes manual lymphatic drainage and compression. The effectiveness of these approaches will be assessed using a specific quality of life questionnaire 15 months after randomization. This multicentric randomized controlled trial seeks to provide evidence for the most effective treatment options for this condition.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options and quality of life for patients suffering from chronic lymphedema after breast cancer.
How similar studies have gone: While conservative treatment is currently the standard, this study is novel as it is the first multicentric randomized controlled trial to compare surgical techniques directly against conservative treatment.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Written informed consent. * Patients ≥ 18 years of age. * Former diagnosis of breast cancer. * Clinical diagnosis of chronic Breast Cancer-Related Lymphedema (BCRL) (persisting for more than 3 months) classified as ≥ Stage 1, according to ISL. * Minimum of 3 months Conservative Complex Physical Decongestion Therapy. * Ability to complete the QoL questionnaires. * Willingness to undergo surgery. Exclusion Criteria: * No indication for lymphatic surgery according to clinical judgment of the treating surgeon (individual reasons will be specifically documented). * Primary congenital Lymphedema or non-BCRL. * Previous surgical BCRL treatment on the side intended for intervention.
Where it's running
-
Harvard Medical School
Boston, Massachusetts, United States Recruiting -
Mayo Clinic
Rochester, Minnesota, United States Recruiting -
Washington University School of Medicine in St. Louis
St Louis, Missouri, United States Recruiting -
University Clinics St.Pölten
Sankt Pölten, Lower Austria, Austria Recruiting -
Krankenhaus Göttlicher Heiland GmbH
Vienna, State of Vienna, Austria Recruiting -
Brussels University Hospital
Brussels, Jette, Belgium Recruiting
Show 30 more locations
-
University of Ghent
Ghent, Belgium Recruiting -
McGill University, Royal Victoria Hospital
Montreal, Canada Recruiting -
University of British Columbia, Gordon and Leslie Diamond Health Care Centre
Vancouver, Canada Recruiting -
BG Universitätsklinikum Bergmannsheil Bochum
Bochum, Germany Recruiting -
Sana Kliniken Düsseldorf
Düsseldorf, Germany Recruiting -
Uniklinikum Erlangen
Erlangen, Germany Recruiting -
KEM Evang. Kliniken Essen-Mitte
Essen, Germany Recruiting -
BG Klinik Frankfurt am Main
Frankfurt, Germany Recruiting -
Universitätsklinikum Freiburg, Klinik für Plastische und Handchirurgie
Freiburg im Breisgau, Germany Recruiting -
BG Klinik Ludwigshafen
Ludwigshafen am Rhein, Germany Recruiting -
Klinikum Nürnberg
Nuremberg, Germany Recruiting -
Caritas Krankenhaus St. Josef/ Uniklinik Regensburg
Regensburg, Germany Recruiting -
Papageorgiou Hospital of Thessaloniki
Thessaloniki, Greece Recruiting -
Policlinico Tor Vergata: Fondazione PTV
Rome, Italy Recruiting -
Policlinico Universitario Fondazione Agostino Gemelli
Rome, Italy Recruiting -
Maastricht University Medical Center
Maastricht, Netherlands Recruiting -
Institute of Oncology ''Prof. Dr. Ion Chiricuță'' of Cluj-Napoca
Cluj-Napoca, Romania Recruiting -
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain Recruiting -
Karolinska Institutet, K1 Molekylär medicin och kirurgi
Stockholm, Sweden Recruiting -
Department of Plastic and Reconstructive Surgery Uppsala University Hospital
Uppsala, Sweden Recruiting -
University Hospital Basel
Basel, Basel, Switzerland Recruiting -
Centre Hospitalier Universitaire Vaudois
Lausanne, Lausanne, Switzerland Recruiting -
Kantonsspital Aarau
Aarau, Switzerland Recruiting -
Hôpitaux Universitaires de Genève
Geneva, Switzerland Recruiting -
Kantonsspital Winterthur
Winterthur, Switzerland Recruiting -
Klinik für Plastische, Rekonstruktive, Aesthetische und Handchirurgie
Zurich, Switzerland Recruiting -
Kaohsiung Chang Gung Memorial Hospital
Kaohsiung City, Taiwan, Taiwan Recruiting -
Yale School of Medicine
New Haven, Connecticut, United States Withdrawn -
Hospital Erasto Gaertner
Paraná, Curitiba, Brazil Withdrawn -
Rambam Health Clinic, ISR
Haifa, Israel Not yet recruiting
Study contacts
- Principal investigator: Elisabeth Kappos, Prof. Dr. — University Hospital, Basel, Switzerland
- Study coordinator: Elisabeth Kappos, Prof. Dr.
- Email: elisabeth.kappos@usb.ch
- Phone: +41 61 328 62 54
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gentle Touch therapy for arm lymphedema after breast cancer surgery
We will test whether adding Gentle Touch lymphatic drainage to usual rehabilitation reduces arm swelling in women aged 30–75 with breast cancer–related lymphedema.
-
Surgery to prevent lymphedema in breast cancer patients
This study is testing whether a special surgery can help prevent lymphedema in breast cancer patients who are having their lymph nodes removed.
-
LYMPHA procedure to prevent arm lymphedema after axillary lymph node removal
This trial will try adding the LYMPHA lymphatic reconstruction at the time of axillary lymph node removal to see if it lowers the risk of lymphedema in adults having lymphadenectomy for breast cancer.
-
Dayspring wearable compression for breast cancer–related arm lymphedema after lymphatic surgery
This study will test whether the Dayspring wearable compression system helps move lymph and reduce arm swelling in adults with breast cancer–related lymphedema after lymphatic surgery.
-
ESWT added to standard lymphedema care for breast cancer patients
This study tests whether adding extracorporeal shock wave therapy to standard lymphedema care helps women with unilateral Stage II breast cancer–related swelling.
-
Pneumatic compression versus manual lymph drainage as part of decongestive care for breast cancer–related lymphedema
This study tests whether adding or replacing manual lymph drainage with intermittent pneumatic compression helps women with unilateral breast cancer–related arm lymphedema.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.